Kennedy Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.8M Sell
236,777
-11,130
-4% -$1.06M 0.55% 32
2025
Q4
$20.1M Buy
247,907
+32,040
+15% +$2.76M 0.43% 56
2025
Q3
$18.9M Buy
215,867
+51,816
+32% +$4.63M 0.42% 55
2025
Q2
$13.6M Sell
164,051
-3,072
-2% -$257K 0.32% 86
2025
Q1
$14M Buy
167,123
+43,307
+35% +$4.03M 0.34% 82
2024
Q4
$11.4M Buy
123,816
+927
+0.8% +$89.1K 0.25% 115
2024
Q3
$11.4M Sell
122,889
-73,289
-37% -$6.35M 0.25% 113
2024
Q2
$16.1M Sell
196,178
-27,508
-12% -$2.02M 0.35% 69
2024
Q1
$14.8M Sell
223,686
-12,723
-5% -$785K 0.31% 85
2023
Q4
$13.4M Sell
236,409
-26,736
-10% -$1.4M 0.29% 96
2023
Q3
$14.3M Sell
263,145
-18,172
-6% -$1.08M 0.35% 71
2023
Q2
$18.9M Sell
281,317
-27,852
-9% -$1.7M 0.44% 40
2023
Q1
$15.9M Sell
309,169
-13,394
-4% -$650K 0.47% 38
2022
Q4
$14.8M Buy
322,563
+52,271
+19% +$2.45M 0.42% 55
2022
Q3
$13.7M Sell
270,292
-20,174
-7% -$1.01M 0.4% 57
2022
Q2
$13.2M Sell
290,466
-111,059
-28% -$4.97M 0.37% 68
2022
Q1
$18.7M Sell
401,525
-24,420
-6% -$1.09M 0.44% 46
2021
Q4
$21.4M Sell
425,945
-12,810
-3% -$662K 0.45% 41
2021
Q3
$23.3M Buy
438,755
+66,628
+18% +$3.75M 0.52% 20
2021
Q2
$22.7M Sell
372,127
-72,527
-16% -$3.85M 0.49% 23
2021
Q1
$21.7M Sell
444,654
-3,185
-0.7% -$149K 0.44% 35
2020
Q4
$18.1M Buy
447,839
+46,102
+11% +$1.65M 0.41% 36
2020
Q3
$13.1M Buy
401,737
+259,817
+183% +$7.8M 0.37% 51
2020
Q2
$3.75M Sell
141,920
-18,800
-12% -$491K 0.11% 355
2020
Q1
$4M Buy
160,720
+1,071
+0.7% +$33.1K 0.15% 259
2019
Q4
$5.74M Sell
159,649
-2,936
-2% -$101K 0.14% 275
2019
Q3
$5.56M Sell
162,585
-6,970
-4% -$223K 0.14% 287
2019
Q2
$4.74M Buy
169,555
+8,949
+6% +$249K 0.11% 344
2019
Q1
$4.98M Sell
160,606
-15,302
-9% -$408K 0.12% 330
2018
Q4
$4.16M Buy
+175,908
New +$4.8M 0.1% 371
2015
Q3
Sell
-69,180
Closed -$834K 733
2015
Q2
$834K Sell
69,180
-38,345
-36% -$377K 0.02% 680
2015
Q1
$901K Sell
107,525
-76,155
-41% -$598K 0.02% 662
2014
Q4
$1.41M Sell
183,680
-35,581
-16% -$255K 0.03% 621
2014
Q3
$1.51M Buy
219,261
+4,661
+2% +$34.8K 0.03% 603
2014
Q2
$1.77M Buy
214,600
+8,613
+4% +$67.3K 0.03% 574
2014
Q1
$1.66M Buy
205,987
+5,194
+3% +$41.5K 0.03% 574
2013
Q4
$1.61M Buy
+200,793
New +$1.55M 0.03% 590

Other funds holding LMAT

Kennedy Capital Management's LMAT Position: Q1 2026 in Review

Kennedy Capital Management reduced its LeMaitre Vascular (LMAT) stake by 4.5% in Q1 2026, selling an estimated $1.06M and leaving 236,777 shares worth $25.8M. The position accounts for 0.55% of the portfolio, ranked #32.

Kennedy Capital Management first reported a position in LMAT in Q4 2013 and has held it in 37 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Kennedy Capital Management held 236,777 shares of LeMaitre Vascular worth $25.8M as of Q1 2026.
  • Kennedy Capital Management sold 11,130 LeMaitre Vascular shares in Q1 2026, an estimated $1.06M.
  • LeMaitre Vascular made up 0.55% of Kennedy Capital Management's portfolio in Q1 2026, its #32 holding.
  • Kennedy Capital Management first reported a position in LeMaitre Vascular in Q4 2013 and has held it in 37 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.